Pharmaceuticals in india
Showing of 0 - 10 from 10 results
Pharmaceuticals in india - Total results - 10
Aug 15, 2013
100% FDI in pharma sector bad for country: Parl committeeThe Parliamentary Committee on Commerce on FDI in the pharmaceutical sector has asked the government to impose a blanket ban on foreign investment in brownfield pharma projects.
Jun 09, 2013
Ranbaxy issue a wake up call for Indian pharma firms: Kiran Mazumdar-ShawThe $500 million fine on Ranbaxy by US authorities after it pleaded guilty to "felony charges" for violating drug manufacturing norms is "a wake up call" for Indian pharmaceutical industry, according to Biocon Chairman and Manging Director Kiran Mazumdar-Shaw.
May 17, 2013
'New drug policy to negatively impact investment in pharmas'"At a company level, we were aware of the upcoming policy and have factored in the impact which is likely to be in the range of 3-4 per cent of our finished dosage sales in India. We have plans in place to ride over this impact," Dr Reddy's Laboratories Vice-Chairman and MD Satish Reddy said.
Dec 27, 2012
IT services, pharma likely to be biggest employers in 2013Information Technology services and pharmaceuticals are likely to drive hiring growth in 2013, to fill mid and senior positions, said HeadHonchos.com, a leading job search and career management portal.
Sep 07, 2012
'Patent drug prices should be set after negotiations with pharma cos'According to industry estimates, there are around 18 patented drugs being marketed in India with a total market value of around Rs 4,000 crore to Rs 5,000 crore, about 12 percent of the overall domestic market
Aug 13, 2012
Sun Pharma gains from rupee fall, lower competition in USAll business segments recorded strong performances with the US segment recording maximum growth.
Aug 06, 2012
Sun Pharma to consider internal restructuring of businessThe Mumbai-headquartered firm said in a filing to the BSE that its board on 10 August "would consider the internal restructuring of the business of the company with effect from 31 March, 2012".
Aug 06, 2012
Divi's Laboratories Q1 net jumps 63% to Rs 167 crorePharmaceuticals firm Divi's Laboratories reported 63.15 percent increase in standalone net profit for the quarter ended 30 June, 2012 at Rs 167.38 crore, driven by higher sales realisation.
Jun 20, 2012
Ranbaxy gains after launching hybrid business model in VenezuelaJapanese pharma major Daiichi Sankyo will sell Ranbaxy's drugs in Venezuela expanding its portfolio of medicines to promote the hybrid business model.
May 07, 2011
Piramal Healthcare: Please take note of displeasurePiramal is sitting on a pile of cash and if put to sensible use, the shareholders will definitely benefit. But what is the company's objective? Will it remain a conglomerate or not?